Biophan Technologies to Participate in yet2.com Conference; Boston Conference Will Focus On Acquiring New Technologies.Business Editors BIOWIRE2K ROCHESTER, N.Y.--(BUSINESS WIRE)--March 17, 2004 Biophan Technologies, Inc. (OTCBB OTCBB See OTC Bulletin Board (OTCBB). : BIPH BIPH Bogomoletz Institute of Physiology (National Academy of Sciences; Ukraine) ) an innovator, developer and marketer of MRI-related and other advanced biomedical technology Biomedical technology involves the application of engineering and technology principles to the domain of living or biological systems. Usually biomedical denotes a greater stress on problems related to human health and diseases. , announced today that it will present at yet2.com's conference, "Proudly Found Elsewhere: Technology Acquisition as a Leading Edge Strategy for R&D." The conference will address best practices for acquiring key new technologies from the outside to speed internal product development, and will take place March 22-23, 2004, at The World Trade Center in Boston, MA. The Conference provides an executive briefing for Chief Executive Officers, Chief Technology Officers, R&D Executives, Strategic Intellectual Asset Managers, Licensing Executives, and Business Managers Biophan will be presenting to and interfacing with an audience of technology managers from many of the largest and most successful companies in the world and presenting along with inventor-entrepreneurs such as Dean Kamen Dean L. Kamen (born April 5, 1951) is an American entrepreneur and inventor. Born in Rockville Centre, New York, he attended Worcester Polytechnic Institute, but dropped out before graduating. His father is Jack Kamen, an illustrator of Weird Science and other EC Comics. and Kevin Rivette. Mr. Weiner will speak on Biophan's genesis from an idea of Wilson Greatbatch* to make future pacemakers safe for MRI 1. (application) MRI - Magnetic Resonance Imaging. 2. MRI - Measurement Requirements and Interface. , to a company with over fifty patents pending, issued, or allowed, covering multiple solutions to allow all biomedical bi·o·med·i·cal adj. 1. Of or relating to biomedicine. 2. Of, relating to, or involving biological, medical, and physical sciences. devices to be MRI safe and image compatible. *Mr. Greatbatch is the inventor of the first successful pacemaker, licensed to Medtronic (NYSE NYSE See: New York Stock Exchange :MDT MDT abbr. Mountain Daylight Time MDT (in the US and Canada) Mountain Daylight Time MDT n abbr (US) (= mountain daylight time) → ), and he developed the technology for the lithium iodine battery used in most implantable devices. He is founder of Wilson Greatbatch Technologies, Inc. (NYSE:GB). About Biophan Technologies Biophan Technologies develops and markets cutting-edge technologies used to make biomedical devices--such as cardiac pacemakers, surgical and diagnostic tools--safe and compatible with magnetic resonance imaging magnetic resonance imaging (MRI), noninvasive diagnostic technique that uses nuclear magnetic resonance to produce cross-sectional images of organs and other internal body structures. (MRI) equipment. The technology is also being used to create enhanced MRI contrast agents. Committed to growth through innovation and developmental leadership, Biophan and its licensors have four issued U.S. patents and over fifty patents pending, in areas including nanomagnetic particle coatings, radio frequency filters, polymer composites, and photonics. Biophan's technology will help realize its goal of one day making all biomedical devices capable of safely and successfully working with MRI. For more information, please visit www.biophan.com. About yet2.com yet2.com Inc and its online marketplace were founded in 1999 to promote technology licensing and transfer, with joint investment from Siemens, Bayer, Honeywell, Dupont, Procter & Gamble, Caterpillar, and NTT DoCoMo. The company has offices in the United States, Europe, and Japan. Its clientele consists of over a quarter of the Fortune 1000. For more information, visit http://www.yet2.com. About the yet2.com Conference For more information on the yet2.com conference, please visit http://www.yet2.com/app/global/en/html/exec_briefing_6.html. Safe Harbor Safe Harbor 1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated. 2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive. Statement: Certain statements included in this press release are forward-looking statements within the meaning of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995. Actual results could differ materially from such statements expressed or implied herein as a result of a variety of factors including, but not limited to: the development of the Company's MRI technologies; the approval of the Company's patent applications; the successful implementation of the Company's research and development programs; the acceptance by the market of the Company's products; competition and the timing of projects and trends in future operating performance, as well as other factors expressed from time to time in the Company's periodic filings with the Securities and Exchange Commission (the "SEC"). As a result, this press release should be read in conjunction with the Company's periodic filings with the SEC. The forward-looking statements contained herein are made only as of the date of this press release, and the Company undertakes no obligation to publicly update such forward-looking statements to reflect subsequent events or circumstances. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion